Anchor Investment Management LLC Sells 2,879 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Anchor Investment Management LLC lowered its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 22.6% during the 2nd quarter, Holdings Channel reports. The firm owned 9,869 shares of the pharmacy operator’s stock after selling 2,879 shares during the quarter. Anchor Investment Management LLC’s holdings in Walgreens Boots Alliance were worth $119,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. Scientech Research LLC purchased a new stake in shares of Walgreens Boots Alliance in the 2nd quarter worth approximately $1,215,000. Syon Capital LLC purchased a new stake in Walgreens Boots Alliance during the fourth quarter worth $333,000. Ariel Investments LLC lifted its holdings in Walgreens Boots Alliance by 10.8% during the second quarter. Ariel Investments LLC now owns 2,038,878 shares of the pharmacy operator’s stock worth $24,660,000 after buying an additional 198,891 shares during the period. Clifford Capital Partners LLC boosted its position in Walgreens Boots Alliance by 58.4% during the 2nd quarter. Clifford Capital Partners LLC now owns 803,204 shares of the pharmacy operator’s stock valued at $9,715,000 after acquiring an additional 296,135 shares in the last quarter. Finally, EP Wealth Advisors LLC purchased a new position in shares of Walgreens Boots Alliance in the 4th quarter valued at $297,000. 58.59% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

WBA has been the subject of a number of analyst reports. JPMorgan Chase & Co. decreased their price objective on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research note on Friday, August 30th. Evercore ISI decreased their price target on shares of Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating for the company in a research report on Friday, June 28th. Morgan Stanley lowered their price target on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating on the stock in a report on Friday, June 28th. Bank of America reduced their price objective on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research note on Wednesday, September 4th. Finally, UBS Group lowered their target price on shares of Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating for the company in a research note on Wednesday, July 3rd. Four investment analysts have rated the stock with a sell rating, ten have issued a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $14.73.

Walgreens Boots Alliance Trading Up 0.6 %

NASDAQ:WBA opened at $8.72 on Friday. The company has a market capitalization of $7.53 billion, a P/E ratio of -1.29, a PEG ratio of 0.99 and a beta of 0.70. The company has a current ratio of 0.65, a quick ratio of 0.31 and a debt-to-equity ratio of 0.49. Walgreens Boots Alliance, Inc. has a 12 month low of $8.22 and a 12 month high of $27.05. The firm has a fifty day simple moving average of $9.73 and a 200-day simple moving average of $13.91.

Walgreens Boots Alliance Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, September 12th. Shareholders of record on Wednesday, August 21st were given a dividend of $0.25 per share. The ex-dividend date was Wednesday, August 21st. This represents a $1.00 dividend on an annualized basis and a yield of 11.47%. Walgreens Boots Alliance’s dividend payout ratio is currently -14.84%.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.